Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R343
R343
Rigel drops asthma drug after mid-stage study fails
Reuters
Mon, 08/26/13 - 08:06 am
Rigel
asthma
R343
Rigel Refuels R&D in $130M Offering
Seeking Alpha
Sun, 05/29/11 - 12:47 pm
Rigel
fostamatinib
rheumatoid arthritis
AstraZeneca
R343
asthma